secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2025-12-10T23:59:59+00:00
Accession:  0001213900-25-120144
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Onconetix boosts interim CEO pay; shareholders OK PIPE issuance for up to 12.8M shares
--------------------------------------------------------------------------------

- Interim CEO Karina Fedasz receives $45,000 bonus for 2025, payable Jan 2026; base comp increased $5,000/month from Jan 1, 2026.
- Annual meeting elects Thomas Meier and Sarah Romano as Class I directors for three-year term.
- Shareholders approve PIPE proposals enabling up to ~12.8M shares from Series D (8.8M) and Series E (4.0M) preferred/warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390025120144/0001213900-25-120144-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390025120144/ea0269184-8k_onconetix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-120144

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer